Angiotensinogen (1-14) (rat)
|
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-LEU-TYR-TYR-SER
|
110200-37-8
|
Angiotensinogen (1-14), porcine
|
血管緊張素原
|
64315-16-8
|
Angiotensinogen(1-13), human
|
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS
|
82048-97-3
|
Renin inhibitory peptide
|
H-PRO-HIS-PRO-PHE-HIS-PHE-PHE-VAL-TYR-LYS-OH
|
75645-19-1
|
Ala-Pro-Gly-(Ile3,Val5)] Angiotensin II
|
ALA-PRO-GLY-ASP-ARG-ILE-TYR-VAL-HIS-PRO-PHE: APGDRIYVHPF
|
72007-47-7
|
Asn1, Val5, Asn9] Angiotensin I, salmon
|
ASN-ARG-VAL-TYR-VAL-HIS-PRO-PHE-ASN-LEU
|
86879-15-4
|
Ile7]-Angiotensin III
|
(DES-ASP1,ILE8)-ANGIOTENSIN II
|
52498-25-6
|
Val4]-Angiotensin III
|
(VAL4)-ANGIOTENSIN III
|
100900-28-5
|
ARG-PRO-GLY-PHE-SER-PRO-PHE-ARG
|
3-去-L-脯氨酸血管舒緩激肽
|
80943-05-1
|
Acetyl-AngiotensinI
|
ACETYL-ANGIOTENSIN I
|
|
Angiogenin (108-122)
|
GLU-ASN-GLY-LEU-PRO-VAL-HIS-LEU-ASP-GLN-SER-ILE-PHE-ARG-ARG
|
112173-49-6
|
Angiogenin (108-123)
|
GLU-ASN-GLY-LEU-PRO-VAL-HIS-LEU-ASP-GLN-SER-ILE-PHE-ARG-ARG-PRO
|
112173-48-5
|
Angiotensin I/II (1-5)
|
ASP-ARG-VAL-TYR-ILE
|
58442-64-1
|
Angiotensin I/II (1-6)
|
ANGIOTENSIN I/II (1-6)
|
47896-63-9
|
Angiotensin I/II (3-7)
|
ANGIOTENSIN I/II (3-7)
|
122483-84-5
|
Angiotensin I/II (3-8)
|
血管緊張素Angiotensin I/II (3-8)
|
23025-68-5
|
Angiotensin II (4-8), human
|
ANGIOTENSIN I/II (4-8)
|
52530-60-6
|
Angiotensin II Antipeptide
|
ANGIOTENSIN II ANTIPEPTIDE
|
121379-63-3
|
Angiotensin II, flounder
|
ASN-ARG-VAL-TYR-ILE-HIS-PRO-PHE
|
|
Angiotensin III Antipeptide
|
GLY-VAL-TYR-VAL-HIS-PRO-VAL
|
133605-55-7
|
Angiotensin(1-12)(human)
|
ANGIOTENSIN (1-12) (HUMAN)
|
136865-09-3
|
Angiotensin(1-12)(mouse, rat)
|
ANGIOTENSIN (1-12) (MOUSE, RAT)
|
914910-73-9
|
PFHLLVYS
|
PFHLLVYS
|
|
Angiotensin II(1-4), human
|
血管緊張素II(1-4),人
|
|
ANGIOTENSIN I/II (5-8)
|
血管緊張素II(5-8)
|
34233-50-6
|
ANGIOTENSIN III, HUMAN
|
血管緊張素III
|
13602-53-4
|
ASN-ARG-VAL-TYR-VAL-HIS-PRO-PHE
|
血管緊張素胺
|
53-73-6
|
(Des-Arg10,Leu9)-Kallidin
|
緩激肽
|
71800-37-8
|
(Des-Arg9,Leu8)-Bradykinin
|
(DES-ARG9,LEU8)-BRADYKININ
|
64695-06-3
|
(Tyr8)-Bradykinin
|
(TYR8)-BRADYKININ
|
32222-00-7
|
Ile-Ser]-Bradykinin
|
T-激肽抗體
|
86030-63-9
|
Met-Lys0] Bradykinin
|
MET-LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG: MKRPPGFSPFR
|
550-19-6
|
Tyr0]Bradykinin
|
TYR-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG: YRPPGFSPFR
|
33289-76-8
|
Bradykinin(2-7)
|
PRO-PRO-GLY-PHE-SER-PRO
|
23828-06-0
|
Kallidin
|
LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG
|
342-10-9
|
Ala107]-MBP(104-118)
|
肽抑制劑[ALA107]-MBP (104-118)
|
99026-77-4
|
Tyr19] Diazepam-Binding Inhibitor Fragment
|
GLN-ALA-THR-VAL-GLY-ASP-VAL-ASN-THR-ASP-ARG-PRO-GLY-LEU-LEU-ASP-LEU-LYS-TYR
|
|
Ala113]-MBP(104-118)
|
肽抑制劑[ALA113]-MBP (104-118)
|
99026-78-5
|
Ala9] Autocamtide 2
|
AUTOCAMTIDE-2-RELATED INHIBITORY PEPTIDE
|
167114-91-2
|
Des-Asp1]-Angiotensin I, Human
|
(DES-ASP1)-ANGIOTENSIN I
|
56317-01-2
|
Lys3, Phe10, Tyr13]-Autocamtide-2-Related Inhibitory Peptide (AIP) Analog
|
LYS-LYS-LYS-LEU-ARG-ARG-GLN-GLU-ALA-PHE-ASP-ALA-TYR
|
|
pThr3]-CDK5 Substrate
|
[PTHR3]-CDK5 SUBSTRATE
|
1670273-47-8
|
Ser25]-PKC (19-36) Substrate
|
ARG-PHE-ALA-ARG-LYS-GLY-SER-LEU-ARG-GLN-LYS-ASN-VAL-HIS-GLU-VAL-LYS-ASN
|
113715-84-7
|
Handle region peptide, rat
|
素原 (PRORENIN) 受體拮抗劑多肽
|
749227-53-0
|
Leptin (116-130) (human)
|
LEPTIN (116-130) (HUMAN)
|
|
Peptide5
|
Peptide 5
|
916977-43-0
|
ALLATOSTATIN IV
|
咽側(cè)體抑制肽 IV
|
123338-13-6
|
PAR-1 (1-6) (mouse, rat)
|
SER-PHE-PHE-LEU-ARG-ASN
|
|
PAR-2 (1-6) amide (human) (scrambled)
|
PAR-2 (1-6) AMIDE (HUMAN) (SCRAMBLED)
|
1348395-60-7
|
PAR-2 (6-1) amide (human)
|
VAL-LYS-GLY-ILE-LEU-SER-NH2
|
|
PAR-2 (6-1) amide (mouse, rat)
|
PAR-2 (6-1) AMIDE (MOUSE, RAT)
|
245329-01-5
|
PAR-3 (1-6) (human)
|
THR-PHE-ARG-GLY-ALA-PRO
|
320347-28-2
|
PAR-4 (1-6) (human)
|
H-甘氨酸-酪氨酸-脯氨酸-甘氨酸-谷氨酸-纈氨酸-OH
|
225779-44-2
|
TRAP-5 amide
|
SER-PHE-LEU-LEU-ARG-NH2
|
141923-41-3
|
VHLTP
|
VHLTP
|
|
Ac2-12
|
膜聯(lián)蛋白A1(1-11)
|
256447-08-2
|
CRP (201-206)
|
C-反應(yīng)蛋白(CRP)201-206
|
130348-99-1
|
CRP (77-82)
|
VAL-GLY-GLY-SER-GLU-ILE
|
|
NA
|
賴氨酸-(脫-精氨酸9)舒緩激肽
|
|
Lys1015, 1024]-Thrombospondin-1(1015-1024), human
|
LYS1015, 1024]-THROMBOSPONDIN-1(1015-1024), HUMAN
|
|
Thrombospondin-1 (1016-1021) (human, bovine, mouse)
|
ARG-PHE-TYR-VAL-VAL-MET
|
149234-06-0
|
Thrombospondin-1 (1016-1023)
|
ARG-PHE-TYR-VAL-VAL-MET-TRP-LYS
|
149234-04-8
|
GHRP
|
醋酸生長激素釋放肽-2
|
158861-67-7
|
GHRP amide
|
GHRP aMide
|
209623-54-1
|
GPRP amide
|
GPRP AMIDE
|
|
Hirudin(54-65)(desulfated);
|
水蛭素
|
113274-56-9
|
Tyr4]-MBP(1-11)
|
AC-ALA-SER-GLN-TYR-ARG-PRO-SER-GLN-ARG-HIS-GLY
|
|
Ac-RYYRIK-amide
|
AC-ARG-TYR-TYR-ARG-ILE-LYS-NH2
|
200959-48-4
|
AKT/PKB/RProtein Kinase Substrate [ARKRERTY-pS-FGHHA], Phosphorylated
|
AKT/PKB/RPROTEIN KINASE SUBSTRATE [ARKRERTY-PS-FGHHA], PHOSPHORYLATED
|
|
Angiotensin II Substrate
|
ASP-ARG-VAL-TYR(PO3H2)-ILE-HIS-PRO-PHE
|
|
Angiotensinogen(1-14), human
|
ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-ASN
|
104180-23-6
|
Anxiety Peptide
|
GLN-ALA-THR-VAL-GLY-ASP-VAL-ASN-THR-ASP-ARG-PRO-GLY-LEU-LEU-ASP-LEU-LYS
|
95237-86-8
|
APYA
|
頭孢他啶EP雜質(zhì)C
|
3432-88-0
|
Biotin-MBP, MAPK Substrate, Phosphorylated
|
BIOTIN-MBP, MAPK SUBSTRATE, PHOSPHORYLATED
|
|
BPP 5a
|
PYR-LYS-TRP-ALA-PRO
|
30505-63-6
|
Calmodulin Dependent Protein Kinase Substrate Analog
|
PRO-LEU-ARG-ARG-THR-LEU-SER-VAL-ALA-ALA-NH2: PLRRTLSVAA-NH2
|
|
cAMP Dependent PK Inhibitor, PKI (14-24), amide
|
GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP-NH2
|
|
Cdc25A (80-93) (human)
|
CDC25A (80-93)
|
851538-67-5
|
CDK5 Substrate
|
PKTPKKAKKL
|
164669-07-2
|
CDK5 Substrate [PKTPKKAKKL], Biotinylated
|
CDK5 SUBSTRATE [PKTPKKAKKL], BIOTINYLATED
|
|
CFTR(108-117), Pseudomonasaeruginosa Inhibitor
|
SER-TYR-ASP-PRO-ASP-ASN-LYS-GLU-GLU-ARG
|
|
CGMP Dependent Kinase Inhibitor Peptide
|
ARG-LYS-ARG-ALA-ARG-LYS-GLU: RKRARKE
|
82801-73-8
|
CTCE9908 peptide
|
CTCE9908 PEPTIDE
|
|
DNA-PK Substrate
|
DNA-PK SUBSTRATE
|
|
EGF Receptor Substrate 2 [DADE-pY-LIPQQG
|
DADEPYLIPQQG
|
|
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], Biotinylated
|
EGF RECEPTOR SUBSTRATE 2 [DADE-PY-LIPQQG], BIOTINYLATED
|
|
EGFR Protein Tyrosine Kinase Substrate [ADEYLIPQQ], Biotinylated
|
EGFR PROTEIN TYROSINE KINASE SUBSTRATE [ADEYLIPQQ], BIOTINYLATED
|
|
epsilon PKC (82-92), C2 Domain
|
EPSILON PKC (82-92), C2 DOMAIN
|
|
Epsilon-V1-2
|
PKCε Inhibitor Peptide
|
182683-50-7
|
epsilon-V1-2, epsilon-PKC Inhibitor, Cys-conjugated
|
epsilon-V1-2, epsilon-PKC Inhibitor, Cys-conjugated
|
|
Fibrinogen Binding Inhibitor Peptide
|
纖維蛋白原結(jié)合抑制劑肽
|
89105-94-2
|
HSDVHK-NH2
|
P11
|
848644-86-0
|
Human PD-L1 inhibitor II
|
HUMAN PD-L1 INHIBITOR II
|
|
delta PKC (8-17)
|
PKC d Inhibitor
|
|
cAMP Dependent PK Inhibitor (5-24), amide
|
GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP-NH2: GRTGRRNAIHD-NH2
|
|
Biotin-MBP, MAPK Substrate
|
BIOTIN-MBP, MAPK SUBSTRATE
|
|
Ac-MBP(1-11)
|
AC-ALA-SER-GLN-LYS-ARG-PRO-SER-GLN-ARG-SER-LYS
|
125366-42-9
|
(Phe1,Ser2)-TRAP-6
|
(PHE1,SER2)-TRAP-6
|
374898-11-0
|
β-Interleukin I (163-171), human
|
VAL-GLN-GLY-GLU-GLU-SER-ASN-ASP-LYS
|
106021-96-9
|
AKT/PKB/RProtein Kinase Substrate [ARKRERTYSFGHHA], Biotinylated
|
AKT/PKB/RPROTEIN KINASE SUBSTRATE [ARKRERTYSFGHHA], BIOTINYLATED
|
|